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Abstract We investigated the prevalence of exercise-
associated hyponatremia (EAH) in 145 male ultra-mara-
thoners at the ‘100-km ultra-run’ in Biel, Switzerland.
Changes in body mass, urinary specific gravity, haemo-
globin, haematocrit, plasma [Na?], and plasma volume
were determined. Seven runners (4.8%) developed
asymptomatic EAH. Body mass, haematocrit and haemo-
globin decreased, plasma [Na?] remained unchanged and
plasma volume increased. D body mass correlated with
both post race plasma [Na?] and D plasma [Na?]. D plasma
volume was associated with post race plasma [Na?]. The
athletes consumed 0.65 (0.30) L/h; fluid intake correlated
significantly and negatively (r = -0.50, p \ 0.0001) to
race time. Fluid intake was neither associated with post
race plasma [Na?] nor with D plasma [Na?], but was
related to D body mass. To conclude, the prevalence of
EAH was low at *5% in these male 100 km ultra-mara-
thoners. EAH was asymptomatic and would not have been
detected without the measurement of plasma [Na?].
Keywords Hyponatremia  Body weight  Sodium 
Hydration status  Fluid
Introduction
Exercise-associated hyponatremia (EAH)–defined as serum
[Na?]\135 mmol/L and described first in 1985 by Noakes
et al. (1985) as being due to ‘water intoxication’–is a well
known and well described fluid and electrolyte disorder in
marathoners, where the prevalence of EAH amounts to
*22% depending upon the number of investigated ath-
letes, their gender and fitness level (Almond et al. 2005;
Chorley et al. 2007; Davis et al. 2001; Hew 2005; Hew
et al. 2003; Kipps et al. 2009; Reid et al. 2004). Risk
factors for EAH are weight gain, exercise duration of more
than 4 h, a slow exercise pace, female gender, a low body
mass, excessive drinking of more than 1.5 L/h while racing,
pre-exercise hyperhydration, abundant availability of
drinking fluids at the event, nonsteroidal anti-inflammatory
drugs, and an extremely hot or cold environment (Hew-
Butler et al. 2005; 2008a; Irving et al. 1991; Noakes et al.
2005; Rosner 2009; Rosner and Kirven 2007). In a data
analysis of 2,135 athletes, weight gain as a consequence of
excessive fluid consumption was the principal cause of a
reduced serum [Na?] after exercise (Noakes et al. 2005). In
recent years, non-osmotic secretion of arginine-vasopres-
sin, combined with high fluid availability, plus sustained
fluid intake, has been hypothesised as leading to an
increase in EAH (Hew-Butler 2010; Rosner 2009). Other
potential mechanisms in the pathogenesis of EAH include
sweat sodium loss, inability to mobilise exchangeable
sodium stores, metabolic water production, and impaired
renal blood flow and glomerular filtration rate (Rosner
2009).
While there is abundant literature about the prevalence
of EAH in marathoners (Almond et al. 2005; Chorley et al.
2007; Davis et al. 2001; Hew et al. 2003; Kipps et al.
2009), studies investigating EAH in ultra-marathoners are
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rare (Fallon et al. 1999; Glace et al. 2002; Noakes and
Carter 1976; Noakes et al. 1990; Page et al. 2007; Reid and
King 2007). Since ultra-marathoners run at a slow pace
(Glace et al. 2002; Knechtle et al. 2009a; Knechtle et al.
2010), they may be at an especially high risk of fluid
overload, and subsequently developing EAH (Hew-Butler
et al. 2005, 2008a; Rosner 2009; Rosner and Kirven 2007).
In a recent study of 45 male ultra-marathoners in a 161 km
ultra-marathon, 51.2% of the finishers presented with EAH
(Lebus et al. 2010). The authors discussed the significantly
longer nature of a 161 km ultra-marathon as a main reason
for the increased prevalence of EAH.
Studies investigating EAH in ultra-marathoners have
been conducted in South Africa (Irving et al. 1991; Noakes
et al. 1990; Noakes and Carter 1976), United States of
America (Glace et al. 2002; Lebus et al. 2010; Stuempfle
et al. 2003), Australia (Fallon et al. 1999; Reid and King
2007), and New Zealand (Page et al. 2007). However,
no study has investigated the prevalence of EAH in a
European ultra-marathon. The aim of this study was to
investigate the prevalence rate of EAH in male ultra-mar-
athoners in the ‘100-km ultra-run’ in Biel, Switzerland.
This race is the most famous 100 km ultra-marathon in
Europe with *1,200 finishers each year from all over
Europe.
Methods
Subjects
Data were collected over four consecutive years in a
100 km ultra-run; the ‘100-km run’ in Biel, Switzerland, in
order to increase the sample size. The Race Director con-
tacted all the participants, in the years 2007–2010, via a
separate newsletter at the time of inscription, in which they
were asked to participate in the study. In 2007, 1,118 male
runners finished, in 2008 1,993, in 2009 1,090 and in 2010
1,059, respectively. A total of 157 male ultra-runners
volunteered to participate in our investigation over this
4 year period. The athletes were informed of the proce-
dures and gave their informed written consent. The study
was approved by the Institutional Review Board for use of
Human Subjects of St. Gallen, Switzerland. Age, anthro-
pometry, training and pre race experience of the subjects is
represented in Table 1.
Race
The ‘100-km run’ in Biel, Berne, Switzerland, generally
takes place during the night of the first weekend in June.
The athletes start the 100 km run on Friday at 10:00 p.m.
They have to climb a total altitude of 645 metres. During
these 100 km, the organiser provides a total of 17 aid
stations offering an abundant variety of food and beverages
(see Table 2). The athletes are allowed to be supported by a
cyclist in order to have additional food and clothing, if
necessary. In all 4 years, the general weather conditions
were comparable, with the temperature at the start being
15–18C, night lows of 8–10C, and daily highs of
25–28C the following day. There was no rain or wind.
Measurements and calculations
Before the start of the race, and after arrival at the finish
line, every subject underwent determination of body mass,
and the collection of capillary blood and urinary samples.
Body mass was measured using a commercial scale
(Beurer BF 15, Beurer GmbH, Ulm, Germany) to the
nearest 0.1 kg. Body height was determined using a stadi-
ometer to the nearest 0.01 m. Capillary blood samples were
taken from the fingertip; plasma [Na?], haemoglobin and
haematocrit were analysed using the i-STAT 1 System
(Abbott Laboratories, Abbott Park, IL, USA). Standardi-
sation of posture prior to blood collection was respected
since postural changes can influence blood volume and
therefore haemoglobin concentration and haematocrit
(Strauss et al. 1951). The percentage change in plasma
volume (%DPV) was calculated from pre- and post-race
levels of haematocrit (Hct) following the equation of
van Beaumont (1972). Urinary specific gravity was ana-
lysed using Clinitek Atlas Automated Urine Chemistry
Analyzer (Siemens Healthcare Diagnostics, Deerfield, IL,
USA). During the race, the athletes recorded their fluid
intake on a sheet of paper which they carried with them
during the run. At each aid station, they marked the number
of consumed cups. In addition, all supplemental fluid intake
Table 1 Age, anthropometry, training and pre race experience of the
145 finishers
Characteristics of subjects
Age (years) 45.7 (9.6)
Body mass (kg) 74.5 (9.2)
Body height (m) 1.78 (0.06)
Body mass index (kg/m2) 23.4 (2.1)
Years as active runner 11.3 (7.9)
Weekly running hours 7.7 (6.7)
Weekly running kilometres 70.9 (28.3)
Speed in running during training (km/h) 10.7 (1.5)
Number of completed marathons (n = 138) 29.4 (47.5)
Personal best marathon time (min) 206 (30)
Number of completed 100 km runs (n = 98) 6.2 (8.3)
Personal best time in a 100 km run (min) 675 (124)
Results are presented as mean (SD)
1008 Eur J Appl Physiol (2011) 111:1007–1016
123
provided by the support crew was recorded. Fluid intake
was estimated according to the reports of the athletes. Upon
inscription to the investigation the participants were
instructed to keep a comprehensive training diary until the
start of the race. All training units in running were recorded,
showing distance in kilometres and duration. In addition,
every athlete indicated his number of finished marathons on
a flat course and his personal best marathon time. Further-
more, the number of finished 100 km runs and the personal
best time in a 100 km was also recorded. Pre race, no
information about fluid intake or the risk of EAH was
provided, either by the race organiser or the investigator. On
arrival for the post race measurements, the athletes were
asked for symptoms of EAH (Hew-Butler et al. 2005,
2008a; Rosner 2009; Rosner and Kirven 2007).
Statistical analysis
Results are presented as mean (SD). The one sample
Wilcoxon signed rank test was used to check for significant
changes (D) in the parameters for all finishers before
and after the race. The results, between hyponatremic and
non-hyponatremic finishers, were compared using the
Mann–Whitney U test. Spearman correlation analysis was
performed to assess the univariate association between D in
the anthropometric variables and D in the laboratory data.
For all statistical tests significance was set at a level of
0.05.
Results
Among these 157 ultra-runners, 145 athletes finished the
100 km within 706 (119) min, competing at an average
running speed of 8.7 (1.4) km/h. Twelve participants did
not finish within the time limit of 21 h. One athlete drop-
ped out due to low back pain, four non-finishers suffered
overuse injuries of the lower limbs, and seven runners
complained about exhaustion. Based on the serum sodium
classification by Noakes et al. (2005), two finishers (1.4%)
were classified as hypernatremic, 136 athletes (93.8%)
were normonatremic and seven ultra-runners (4.8%) were
hyponatremic. Hyponatremic finishers were asymptomatic.
Hyponatremic finishers were no slower compared to non-
hyponatremic finishers (see Table 3). There was also no
difference between them regarding training and pre race
experience. The number of completed marathons (r = 0.23,
p = 0.0077), the personal best marathon time (r = 0.71,
p \ 0.0001) and the personal best 100 km time (r =
0.77, p \ 0.0001) were related to race time for all finishers.
While running, the athletes consumed a total of 7.3 (3.0)
L over the 100 km, equal to 0.65 (0.30) L/h. Fluid intake
varied between 0.27–1.62 L/h and correlated negativelyT
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and significantly to race time (see Fig. 1). Hyponatremic
finishers were drinking no more compared with non-hyp-
onatremic ones (see Table 3). For all 145 finishers, body
mass decreased, plasma [Na?] remained stable, haemato-
crit and haemoglobin decreased and urinary specific grav-
ity increased (see Table 4). In both hyponatremic and
non-hyponatremic finishers, haematocrit and haemoglobin
decreased, and urinary specific gravity increased (see
Table 5). Plasma [Na?], however, decreased in the
hyponatremic finishers, but not in the non-hyponatremic
finishers. Plasma volume increased by 6.1 (15.6) % for all
finishers. In the hyponatremic finishers, plasma volume
increased significantly higher by 15.2 (9.7) %; in the non-
hyponatremic finishers, by 5.5 (12.6) % (p \ 0.05).
D body mass correlated to both post race plasma [Na?]
(see Fig. 2) and D plasma [Na?] (see Fig. 3) but not to
finishing time (see Fig. 4). Post race plasma [Na?] corre-
lated positively and significantly with D plasma [Na?]
(r = 0.73, p \ 0.0001). Fluid intake was neither associated
with post race plasma [Na?] nor with D plasma [Na?].
Fluid intake was related to D body mass (see Fig. 5), but
not to post race body mass. Fluid intake showed no cor-
relation to post race urinary specific gravity, D urinary
specific gravity or D plasma volume. D plasma volume was
associated with post race plasma [Na?] (r = -0.29,
p = 0.0375), but not with D [Na?], post race body mass, or
D body mass. Race time showed no association with post
race body mass, D body mass, post race plasma [Na?], D
plasma [Na?], post race urinary specific gravity or D uri-
nary specific gravity.
Discussion
The aim of this study was to investigate the prevalence of
EAH in male ultra-marathoners in a European ultra-mara-
thon. Seven runners (4.8%) developed asymptomatic EAH.
Regarding the existing literature on EAH in ultra-mara-
thoners, the prevalence of EAH seems generally to be
lower in ultra-marathoners compared to marathoners,
Table 3 Comparison of
anthropometry, pre race
experience, fluid intake and
performance between
hyponatremic and non-
hyponatremic finishers
Results are presented as mean
(SD). No differences were
found between hyponatremic
and non-hyponatremic finishers
Hyponatremic
finishers (n = 7)
Non-hyponatremic
finishers (n = 138)
p value
Age (years) 47.7 (12.5) 45.6 (9.5) n.s.
Body mass (kg) 70.2 (7.6) 74.8 (9.3) n.s.
Body height (m) 1.76 (0.07) 1.79 (0.07) n.s.
Body mass index (kg/m2) 22.6 (1.7) 23.4 (2.2) n.s.
Years as active runner (years) 6.7 (5.0) 11.5 (8.0) n.s.
Weekly running hours (h) 8.9 (4.1) 7.6 (6.8) n.s.
Weekly running kilometres (km) 88.6 (27.5) 70.0 (28.1) n.s.
Speed in running during training (km/h) 10.7 (0.9) 10.7 (1.5) n.s.
Number of completed marathons (n) 20.5 (30.3) (n = 6) 29.8 (48.2) (n = 132) n.s.
Personal best marathon time (min) 192 (10) 207 (31) n.s.
Number of completed 100 km runs (n) 9.7 (13.3) (n = 3) 6.0 (8.2) (n = 94) n.s.
Personal best time in a 100 km run (min) 616 (36) 677 (125) n.s.
Fluid intake (L) 6.2 (2.3) 7.3 (3.1) n.s.
Fluid intake (L/h) 0.58 (0.23) 0.65 (0.30) n.s.
Fluid intake (mL/h/kg body mass) 8.3 (3.3) 8.7 (4.3) n.s.
Race time (min) 640 (74) 710 (120) n.s.
Running speed in the race (km/h) 9.4 (0.9) 8.7 (1.4) n.s.
400
500
600
700
800
900
1000
1100
1200
0.2 0.7 1.2 1.7
Fluid intake (L/h)
R
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Fig. 1 Fluid intake correlated significantly and negatively with race
time for the 145 finishers (r = -0.50, p \ 0.0001)
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although Stuempfle et al. (2002) described a prevalence of
44% of EAH in ultra-marathoners and Lebus et al. (2010)
of 51.2%. Noakes et al. (1990) found symptomatic EAH in
0.3% of ultra-marathoners finishing a 90 km ultra-mara-
thon with a total of 18,031 finishers. In a 161 km race,
however, no case of EAH occurred, although decreased
plasma [Na?] after the race was due to fluid overload
caused by excessive fluid consumption (Stuempfle et al.
2003). Also Reid and King (2007) and Glace et al. (2002)
found no case of EAH in ultra-marathoners.
In a very recent study of 161 km ultra-marathoners,
however, the prevalence of EAH amounted to *50%
(Lebus et al. 2010). The 45 athletes in that study competed
Table 4 Changes in body
mass, haematologic and urinary
parameters for the 145 finishers
Results are presented as mean
(SD)
*** p \ 0.001
Pre race Post race Change (absolute) Change (%)
Body mass (kg) 74.5 (9.2) 72.7 (9.1) -1.8 (1.4) *** -2.4 (1.8)
Plasma [Na?] (mmol/L) 138.0 (2.3) 138.5 (2.7) ?0.5 (3.4) ?0.4 (2.5)
Haematocrit (%) 45.3 (4.2) 44.0 (3.4) -1.3 (3.2) *** -2.4 (6.6)
Haemoglobin (g/dL) 15.3 (1.5) 15.0 (2.5) -0.3 (2.4) *** -1.6 (15.5)
Urinary specific gravity (g/mL) 1.014 (0.008) 1.024 (0.006) ?0.009 (0.007) *** ?0.98 (0.74)
Table 5 Comparison of changes in body mass, haematologic and urinary parameters within hyponatremic and non-hyponatremic finishers
Hyponatremic finishers (n = 7) Non-Hyponatremic Finishers (n = 138)
Pre race Post race D (post–pre) Pre race Post race D (post–pre)
Body mass (kg) 70. 2 (7.6) 68.4 (7.3)* -1.8 (0.9) 74.8 (9.3) 73.0 (9.1)* -1.8 (1.4)
Plasma [Na?] (mmol/L) 137.0 (3.6) 133.1 (1.5)* -3.9 (3.1)# 138.1 (2.2) 138.8 (2.5) ?0.7 (3.3)
Haematocrit (%) 45.0 (3.7) 41.6 (3.3)* -3.4 (2.2)# 45.3 (4.2) 44.2 (3.3)* -1.1 (3.2)
Haemoglobin (g/dL) 15.3 (1.3) 14.1 (1.1)* -1.2 (0.7)# 15.3 (1.4) 14.9 (1.2)* -0.4 (1.0)
Urinary specific gravity (g/mL) 1.007 (0.004) 1.020 (0.009)* ?0.013 (0.006) 1.015 (0.007) 1.025 (0.008)* ?0.010 (0.007)
Results are presented as mean (SD)
* Significant difference within the group
# Significant difference between the groups
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Fig. 2 The change in body mass was significantly and negatively
associated with post race plasma [Na?] in the 145 finishers (r =
-0.35, p \ 0.0001)
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Fig. 3 The change in body mass was significantly and negatively
associated with the change in plasma [Na?] in the 145 finishers
(r = -0.34, p \ 0.0001)
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for *26 h, considerably longer compared to our ultra-
runners who completed the 100 km within *12 h. Lebus
et al. (2010) discussed the significantly longer nature of a
161 km ultra-marathon, compared to a marathon, as a main
risk factor for the high prevalence of EAH. The considerably
larger difference of *5% EAH in our 100 km ultra-mara-
thoners compared to *50% EAH in the 161 km ultra-mar-
athoners of Lebus et al. (2010) is, however, striking. A reason
for the notably higher prevalence of EAH in Lebus et al.
(2010) could be the higher ambient temperature at the ‘Rio
Del Lago 100-Mile Endurance Run’ of 12.2–37.6C, com-
pared with the lower temperatures at Biel, Switzerland. An
extremely hot or cold environment is considered as a risk
factor for EAH (Hew-Butler et al. 2005, 2008a; Rosner 2009;
Rosner and Kirven 2007).
Considering the aid stations and the nutrition provided,
the two races were comparable. Lebus et al. (2010), how-
ever, acknowledged that their investigation was limited
since fluid and nutrition intake was not recorded. In the
‘Rio Del Lago 100-Mile Endurance Run’, 24 aid stations
were offered at *7 km; in the ‘100-km run’ in Biel, the
athletes could feed at 17 aid stations at *6 km. In both
races salt was offered. In the ‘Rio Del Lago 100-Mile
Endurance Run’ salty snacks were provided; in the ‘100-
km run’ in Biel the athletes could drink soup. In contrast to
Lebus et al. (2010), we were able to determine fluid intake,
however, the sodium intake would also be interesting. It
has been shown that the risk of EAH can be minimised by
the use of replacement fluids of high sodium concentrations
while running for 4 h (Twerenbold et al. 2003). However,
studies at ultra-endurance races such as an Ironman tri-
athlon showed that oral sodium supplementation was not
necessary to prevent hyponatremia (Hew-Butler et al.
2006; Speedy et al. 2002). Also sodium ingestion may not
be of much advantage when athletes replace only *50% of
their fluid loss during performances at 32C (Sanders et al.
1999). Sodium supplementation might, however, be of
importance in a hot environment. When fluid intake mat-
ches sweat loss, sodium intake during prolonged exercise
in the heat, at 30C, plays a significant role in preventing
sodium losses that may lead to hyponatremia (Anastasiou
et al. 2009). At 30C, saline intake, however, was not
associated with significantly higher plasma sodium during
exercise compared to water intake (Barr et al. 1991). Sweat
loss might be of importance at high ambient temperatures
regarding the risk of EAH. At 34C, decreased plasma
sodium concentration can result from replacing sweat loss
with plain water, when sweat losses are large, and can
precipitate the development of hyponatremia (Vrijens and
Rehrer 1999).
A further reason for the different findings in plasma
[Na?] in Lebus et al. (2010) compared to our results might
be the device used in the determination of plasma [Na?]. In
both investigations, however, the i-STAT 1 System
(Abbott Laboratories, Abbott Park, IL, USA) was used to
determine plasma [Na?]. Lebus et al. (2010) reported
malfunctions in the pre race determination of plasma
[Na?], whereas we had no malfunctions. The reason for the
malfunctions might have been the higher ambient tem-
perature at the ‘Rio Del Lago 100-Mile Endurance Run’
compared to our race.
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Fig. 4 The change in body mass was not related to finishing times
(r = 0.03, p [ 0.05) for the 145 finishers
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Fig. 5 Fluid intake was significantly and positively related to the
change body mass (r = 0.21, p = 0.012) in the 145 finishers
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Fluid overload due to overdrinking is the main risk
factor for EAH (Hew-Butler et al. 2005, 2008a; Irving et al.
1991; Noakes et al. 2005; Rosner 2009; Rosner and Kirven
2007). Weight gain, as a consequence of excessive fluid
consumption, was the principal cause of a reduced serum
[Na?] after exercise when 2,135 athletes were analysed
(Noakes et al. 2005). The way to minimise the risk of EAH
is not to overdrink during exercise (Beltrami et al. 2008).
This is clearly shown by all the studies in which athletes
are advised not to overdrink during exercise. In those races,
the risk of EAH is negligible. Examples are the 90 km
Comrades Marathon in South Africa (Noakes and Carter
1976; Noakes et al. 1990), the Ironman South Africa
(Sharwood et al. 2002; Sharwood et al. 2004) and the
Ironman New Zealand (Speedy et al. 2000) where the
advice to reduce fluid intake reduced the incidence of EAH
dramatically.
In this race, the athletes were offered 17 refreshment
points over the 100 km, on average every 5.9 km. Our
ultra-marathoners consumed––despite the increased avail-
ability of aid stations––on average 0.65 (0.30) L/h. In the
‘Position Statement’ of IMMDA, marathoners should drink
no more than 400–800 mL/h ad libitum, according to their
thirst (Noakes 2003). These ultra-marathoners met––with a
mean fluid intake rate of 0.65 (0.30) L/h––the recommen-
dations of IMMDA exactly. An interesting finding was the
fact that fluid intake was significantly and negatively
related to race time where faster runners were consuming
more fluids than slower ones. In marathoners, EAH was
associated with increased fluid consumption during the
race because slower athletes showed a higher drinking
frequency compared with faster ones (Almond et al. 2005;
Kipps et al. 2009; Mettler et al. 2008). Although our faster
athletes consumed significantly more fluids, race time was
neither associated with post race plasma [Na?] nor with D
plasma [Na?]. This is in contrast to the opinion that high
fluid consumption leads to dilutional hyponatremia
(Verbalis 2007). The athletes in this race, compared to a
marathon race, had the opportunity of being followed by a
support crew member, mainly a cyclist. This cyclist can
carry food and drinks as well as clothes. We assume that
the faster runners were followed by a support crew pro-
viding fluids between the aid stations so the athlete did not
have to stop at aid stations to get a drink. Presumably, a
runner finishing in the top 10 will not stop at the refresh-
ment points, but rather consume fluids from the support
crew while running. For example, one athlete finishing
within 504 min (8 h 24 min) drank 9.8 L of fluids, equal to
1.34 L/h. Experienced ultra-runners with a fast race time
were obviously able to consume rather large amounts of
fluids so that neither dehydration nor fluid overload
occurred. Alternatively, the faster runners had greater
sweat rates, due to the higher speed, than the slower run-
ners and, therefore, consumed more fluids.
In case of fluid overload, we expected an increase in
body mass and a decrease in plasma [Na?] (Hew-Butler
et al. 2005, 2008a; Rosner 2009; Rosner and Kirven 2007).
Fluid intake was related to D body mass in these ultra-
marathoners, but not to post race body mass. Furthermore,
fluid intake was neither related to post race plasma [Na?]
nor to D plasma [Na?]. Glace et al. (2002) described a
significant and negative relationship between fluid intake
and post race plasma [Na?] in their ultra-marathoners; high
fluid intakes were correlated with lower post race plasma
[Na?]. Their ultra-runners consumed 19.4 (5.6) L during
the 26.2 (0.4) h, on average 0.74 L/h. This was slightly
more compared with our runners consumption of 0.65
(0.30) L/h and might be the reason for the lower post race
plasma [Na?] concentration. Weight gain during endurance
exercise is associated with EAH (Hew-Butler et al. 2005,
2008a; Noakes et al. 2005; Rosner 2009; Rosner and
Kirven 2007). The determination of D body mass is a
useful measure of both fluid intake (Almond et al. 2005)
and fluid retention (Siegel et al. 2007). These ultra-mara-
thoners, however, lost *1.8 kg body mass. A decrease in
body mass is––apart from other parameters––a marker of
dehydration (Shirreffs 2003; Kavouras 2002) and we
assume that these ultra-marathoners were rather dehydrated
than overhydrated. A loss of 2 kg body mass could also be
purely due to energy loss and fluid associated with glyco-
gen. Those athletes who lost 2 kg body mass would
probably not have shown any change in their total body
water. Nolte et al. (2010) showed recently that a reduction
in body mass of 1.4% was not associated with a reduction
in total body water in 15 soldiers performing a 16.4 km
route march. Body mass change, however, is not always a
reliable measure of changes in hydration status, and sub-
stantial loss of mass may occur without an effective net
negative fluid balance (Maughan et al. 2007). Following
the ‘Statement of the Consensus Conference’ and the large
data analysis of 2,135 athletes, a loss of *2% body mass
seems to be preventative against EAH (Hew-Butler et al.
2008a; Noakes et al. 2005). Body mass changes correlated
with both post race plasma [Na?] and D plasma [Na?].
This is in line with the recent findings of the marathon
runners of Mettler et al. (2008), where D body mass cor-
related with both post race plasma [Na?] and D plasma
[Na?]. Post race plasma [Na?] correlated to D plasma
[Na?] in their marathoners as has been found in our ultra-
marathoners. Mettler et al. (2008) demonstrated a signifi-
cant association between both post race plasma [Na?] and
post race plasma osmolality, and they speculated that the
increased plasma osmolality might be due to an increased
activity of vasopressin.
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Haematocrit decreased during this ultra-marathon and
plasma volume increased by 6.0 (12.6) %. During a mar-
athon, however, plasma volume decreased (Maughan et al.
1985; Whithing et al. 1984), as has also been found in an
ultra-marathon over 67 km (Rehrer et al. 1992). In longer
ultra-endurance races, however, plasma volume increased
(Hew-Butler et al. 2007; Stuempfle et al. 2003). Hew-
Butler et al. (2007) assumed that the intensity was
responsible for these disparate findings since marathoners
compete faster compared with ultra-marathoners. Ultra-
endurance athletes may preserve a ‘fluid reserve’ in the
interstitial fluid of the extracellular fluid compartment. An
interesting finding in our subjects was the fact that hae-
matocrit and haemoglobin decreased significantly more in
hyponatremic finishers compared to non-hyponatremic
ones and that plasma [Na?] decreased in hyponatremic
finishers, whereas plasma [Na?] remained stable in non-
hyponatremic finishers. Plasma volume increased more in
hyponatremic compared with non-hyponatremic finishers.
This increase in plasma volume might, however, also be
due to an increased activity of aldosterone during a 100 km
run (Keul et al. 1981). Fellmann et al. (1999) concluded
that the increase in plasma volume after an ultra-endurance
race was mainly due to sodium retention. In a 24 h race,
they found an increase in plasma volume, aldosterone and
vasopressin (Fellmann et al. 1989). Stuempfle et al. (2003)
showed an increased activity of both aldosterone and
vasopressin after an ultra-endurance race. Presumably, the
increase in plasma volume is due to an increased activity of
both vasopressin and aldosterone.
Changes in body mass and urinary specific gravity are
considered as reliable markers of change in hydration sta-
tus (Shirreffs 2003; Kavouras, 2002). The post race urinary
specific gravity of[1.020 mg/L indicated dehydration; the
loss of *2.4% body mass (*1.8 kg body mass) indicated
minimal dehydration (Kavouras 2002). These ultra-runners
were dehydrated, with a decrease in body mass and with
post race urinary specific gravity [1.020 mg/L, according
to the concept of determination of hydration status
(Kavouras 2002; Shirreffs 2003). The decrease in body
mass might, however, also be due to a decrease in solid
mass such as fat mass and skeletal muscle mass, as has
been shown in recent studies of ultra-runners (Knechtle
et al. 2009c; Knechtle et al. 2010). Considering the asso-
ciations of D body mass with both post race plasma [Na?]
and D plasma [Na?], and respecting recent literature, body
fluid must have been increased. Fluid intake was not
related to D plasma [Na?] and other factors might be
responsible for fluid regulation in ultra-endurance runners.
We assume that other factors maintained body fluid
homeostasis during this ultra-marathon, such as a hormonal
regulation by vasopressin and aldosterone (Fellmann et al.
1989; Stuempfle et al. 2003). In recent studies of
marathoners (Siegel et al. 2007) and ultra-marathoners over
56 km (Hew-Butler et al. 2008b), the activity of vaso-
pressin was measured in addition to body mass, plasma
[Na?], osmolality and fluid intake. Recent findings sug-
gested that EAH was not only due to fluid overload but also
to an increased activity in vasopressin (Hew-Butler 2010;
Verbalis 2007). In future studies of 100 km ultra-runners
the activity of vasopressin should also be investigated.
Since sodium retention was the major factor in the increase
in plasma volume (Fellmann et al. 1999), and aldosterone
was increased after an ultra-endurance race (Stuempfle
et al. 2003), the activity of aldosterone should also be
determined. Furthermore, changes in total body water
should be determined (Nolte et al. 2010). This might pro-
vide more insight into fluid and electrolyte regulation in
ultra-marathoners.
Event inexperience is one of the athlete-related risk
factors for EAH (Hew-Butler et al. 2005, 2008a; Rosner
2009; Rosner and Kirven 2007). In marathoners, the
number of pre race completed marathons varied between
one and eight races (Almond et al. 2005; Chorley et al.
2007; Kipps et al. 2009; Mettler et al. 2008) and non-
hyponatremic finishers in a marathon had completed more
marathons compared to non-hyponatremic finishers
(Almond et al. 2005). In these studies, the prevalence rate
of EAH amounted to *22% (Almond et al. 2005; Chorley
et al. 2007; Kipps et al. 2009; Mettler et al. 2008). Our
100 km ultra-runners had completed *30 marathons pre
race and 98 athletes (67%) had already completed *6
100 km ultra-runs. Interestingly, both hyponatremic and
non-hyponatremic finishers showed no differences regard-
ing the number and the personal best times in both mara-
thons and 100 km ultra-marathons. Due to the low
prevalence of EAH in our ultra-marathoners, we assume
that pre race experience is an important determinant in
minimising the risk of EAH (Kruseman et al. 2005). The
personal best time in a 100 km ultra-run showed about the
same correlation coefficient (r = 0.77) compared to a
personal best marathon time (r = 0.71) with the 100 km
race time. A personal best marathon time might be an
independent predictor variable for an ultra-running per-
formance; in a 24 h run, the personal best marathon time
was related to total running kilometres (Knechtle et al.
2009b).
A limitation of this study is that only 145 out of 5,260
finishers (2.7% of the finishers) were included. Although
the number of investigated finishers is relatively high, a
selection bias can probably not be excluded. We did not
ask about the intake of nonsteroidal anti-inflammatory
medication, which is also considered as a risk factor for
EAH (Hew-Butler et al. 2008a). The use of nonsteroidal
anti-inflammatory drugs might influence renal function
(Reid et al. 2004) and increase the risk of exercise-
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associated hyponatremia (Page et al. 2007). A further
limitation is that we did not determine plasma [Na?] in the
non-finishers, so if any of these 12 non-finishers did suffer
from EAH the prevalence of EAH would have doubled.
Conclusions
To summarise, the prevalence of EAH in 100 km ultra-
marathoners was lower compared to reports on marathon-
ers and a recent report on 161 km ultra-marathoners. EAH
was asymptomatic and would not have been detected
without the measurements of plasma sodium concentra-
tions. Plasma volume increased and plasma [Na?] was
maintained although body mass decreased. Fluid intake
showed no association with the increase in plasma volume,
post race plasma [Na?] and D plasma [Na?]. Hydration
status was adequately maintained as has been found in
other ultra-endurance races (Tam et al. 2009; Hew-Butler
et al. 2007; Rose and Peters, 2008). The determination of
changes in total body water and of the activity of both
aldosterone and vasopressin in ultra-marathoners might
give more insight into maintaining body fluid homeostasis
in ultra-endurance performances.
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